SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001607062-17-000338
Filing Date
2017-10-13
Accepted
2017-10-13 13:26:32
Documents
4
Period of Report
2017-10-13
Effectiveness Date
2017-10-13

Document Format Files

Seq Description Document Type Size
1 gnbt101317sched14a.htm DEF 14A 1859900
2 GRAPHIC img001.gif GRAPHIC 18399
3 GRAPHIC image_001.gif GRAPHIC 15604
4 GRAPHIC image_002.gif GRAPHIC 6629
  Complete submission text file 0001607062-17-000338.txt   1916919
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0320
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 171136232
SIC: 2834 Pharmaceutical Preparations